| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.69 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |